Photo of Nury H. Yoo
  • On May 26, 2020, the U.S. Food and Drug Administration (FDA) and Federal Trade Commission (FTC) issued joint warning letters to four companies for the marketing and sale of products


Continue Reading FDA and FTC Issue Warning Letters to Companies Marketing and Selling Products Deemed Fraudulent for the Treatment or Prevention of COVID-19

  • On May 14, 2020, the Hon. Ronald A. White, a federal judge in the United States District Court for the Eastern District of Oklahoma, issued a Temporary Restraining Order (“TRO”)


Continue Reading Federal Court Enters Temporary Restraining Order Against Xephyr LLC (dba N-Ergetics) to Prevent the Sale and Distribution of Colloidal Silver Products for Treatment of COVID-19

  • On March 13, 2020, Ultimate Brain Nutrients, LLC (“UBN”) submitted a Petition (which FDA filed and posted for comprehensive review on April 30, 2020), seeking FDA’s authorization of a qualified


Continue Reading FDA Posts Qualified Health Claim Petition Regarding MCTs Caprylic and Capric Acid for Use in the Management of Migraine Headaches